/PRNewswire/ -- USANewsGroup.com News Commentary - Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the

FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc. (NASDAQ: HYPR) (“Hyperfine”), with an initial funding of $15 million at closing, and up to $25 million available to support future commercial growth. Hyperfine is a publicly traded health technology company that has developed and is commercializing the Swoop® System, t.

Hyperfine (NASDAQ: HYPR - Get Free Report) and Atossa Genetics (NASDAQ: ATOS - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk. Analyst Recommendations This is a summary of current

Hyperfine, Inc. (HYPR) Q4 2025 Earnings Call Transcript

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2025 financial results and provided a business update. “The launch of our second-generation Swoop® scanner, our Optive AI™ software, and the addition of a new market in the neurology office setting in.

Hyperfine (NASDAQ: HYPR - Get Free Report) and Arrayit (OTCMKTS:ARYC - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, institutional ownership and profitability. Valuation and Earnings This table compares Hyperfine and Arrayit"s revenue,

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the fourth quarter and full year 2025 on Wednesday, March 18, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archiv.

Hyperfine, Inc. (NASDAQ: HYPR - Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 1,250,028 shares, a growth of 46.4% from the December 31st total of 854,005 shares. Based on an average trading volume of 487,628 shares, the

GUILFORD, Conn.--(BUSINESS WIRE)--Strong evidence supports the use of AI-powered portable MRI for stroke detection in multiple clinical settings, including the emergency department.

GUILFORD, Conn.--(BUSINESS WIRE)--Results from the NEURO PMR study, presented by Dr. Laszlo Mechtler at the ASN Annual Meeting in San Juan, Puerto Rico, on January 16, 2026.